1. Hobson C, Lysak N, Huber M, Scali S, Bihorac A. Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient.
J Vasc Surg 2018;68:916–928.
2. Nie S, Tang L, Zhang W, Feng Z, Chen X. Are there modifiable risk factors to improve AKI?
Biomed Res Int 2017 2017:5605634.
3. Sawhney S, Fraser SD. Epidemiology of AKI: utilizing large databases to determine the burden of AKI.
Adv Chronic Kidney Dis 2017;24:194–204.
4. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant mechanisms in renal injury and disease.
Antioxid Redox Signal 2016;25:119–146.
5. Agarwal A, Dong Z, Harris R, et al. Acute Dialysis Quality Initiative XIII Working Group. Cellular and molecular mechanisms of AKI.
J Am Soc Nephrol 2016;27:1288–1299.
6. Pavlakou P, Liakopoulos V, Eleftheriadis T, Mitsis M, Dounousi E. Oxidative stress and acute kidney injury in critical illness: pathophysiologic mechanisms-biomarkers-interventions, and future perspectives.
Oxid Med Cell Longev 2017 2017:6193694.
7. Nusshag C, Weigand MA, Zeier M, Morath C, Brenner T. Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review.
Int J Mol Sci 2017;18:E1387
8. Pakniyat A, Yousefichaijan P. Evaluation and management of children with acute kidney injury in emergency department.
J Nephropharmacol 2015;4:83–84.
9. Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018.
Am J Kidney Dis 2018;72:136–148.
10. Fiorentino M, Kellum JA. Improving translation from pre-clinical studies to clinical trials in acute kidney injury.
Nephron 2018;140:81–85.
11. Yang Y, Song M, Liu Y, et al. Renoprotective approaches and strategies in acute kidney injury.
Pharmacol Ther 2016;163:58–73.
12. Dennis JM, Witting PK. Protective role for antioxidants in acute kidney disease.
Nutrients 2017;9:E718
13. Boozari M, Hosseinzadeh H. Natural medicines for acute renal failure: a review.
Phytother Res 2017;31:1824–1835.
14. Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment.
J Renal Inj Prev 2015;4:20–27.
15. Palipoch S. A review of oxidative stress in acute kidney injury: protective role of medicinal plants-derived antioxidants.
Afr J Tradit Complement Altern Med 2013;10:88–93.
16. Sierra-Pérez RC, González-Canavaciolo VL, Rodríguez-Leyes EA, Marrero-Delange D, Vicente-Murillo R, Morales-Rico CL. Estudio fitoquímico de los frutos de Acrocomia crispa, palma endémica cubana. Rev CENIC Cienc Quím 2014;45:41–47.
17. Pérez Y, Oyarzábal A, Sierra R, et al. Inhibition of cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) by D-005 (a lipid extract of Acrocomia crispa fruits). Bol Latinoam Caribe Plant Med Aromat 2017;16:319–328.
18. Mena L, Sierra R, Valle M, et al. Acrocomia crispa fruits lipid extract prevents LPS-induced acute lung injury in mice.
Bol Latinoam Caribe Plant Med Aromat 2019;18:16–26.
19. Pérez Y, Oyarzábal A, Sierra R, et al. Oral administration of D-005, a lipid extract from Corojo palm (Acrocomia crispa) fruits, attenuates testosterone induced prostate enlargement and increased oxidative stress in rats. Acad J Pharm Pharmacol 2016;4:10–15.
20. Oyarzábal Yera A, Rodríguez Salgueiro S, Merino García N, et al. Efecto nefroprotector del D-005, extracto lipídico del fruto de Acrocomia crispa, en un modelo de isquemia-reperfusión renal en ratas. Actas de Congreso Morfovirtual 2018.
21. Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury.
J Am Soc Nephrol 2009;20:2412–2425.
22. Zhang J, Xia J, Zhang Y, et al. HMGB1-TLR4 signaling participates in renal ischemia reperfusion injury and could be attenuated by dexamethasone-mediated inhibition of the ERK/NF-κB pathway.
Am J Transl Res 2016;8:4054–4067.
23. Jacob KA, Leaf DE, Dieleman JM, et al. Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery.
J Am Soc Nephrol 2015;26:2947–2951.
24. Witzig TE, Johnston PB, LaPlant BR, et al. Long-term follow-up of chemoimmunotherapy with rituximab, ox-aliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU).
Am J Hematol 2017;92:1004–1010.
25. Changizi Ashtiyani S, Najafi H, Jalalvandi S, Hosseinei F. Protective effects of Rosa canina L fruit extracts on renal disturbances induced by reperfusion injury in rats.
Iran J Kidney Dis 2013;7:290–298.
26. Najafi H, Firouzifar MR, Shafaat O, Changizi Ashtiyani S, Hosseini N. Protective effects of Tribulus terrestris L extract against acute kidney injury induced by reperfusion injury in rats.
Iran J Kidney Dis 2014;8:292–298.
27. Ortiz A, Sanchez-Niño MD, Izquierdo MC, et al. Red de In-vestigacion Renal (REDINREN) and Consorcio Madrileño para investigación del fracaso renal agudo (CIFRA). Translational value of animal models of kidney failure.
Eur J Pharmacol 2015;759:205–220.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.
Anal Biochem 1979;95:351–358.
29. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.
Anal Biochem 1978;87:206–210.
30. Hu ML. Measurement of protein thiol groups and glutathione in plasma.
Methods Enzymol 1994;233:380–385.
31. Aebi H. Catalase. In: Bergmeyer HU, Gawehn K,
Methods of enzymatic analysis. 2nd ed. New York: Academia Press; 1974. p. 673–684.
32. Fiorentino M, Castellano G, Kellum JA. Differences in acute kidney injury ascertainment for clinical and preclinical studies.
Nephrol Dial Transplant 2017;32:1789–1805.
33. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/re-perfusion.
Compr Physiol 2016;7:113–170.
34. Zuk A, Bonventre JV. Acute kidney injury.
Annu Rev Med 2016;67:293–307.
35. Tavafi M. Suggestions for attenuation of renal ischemia re-perfusion injury based on mechanisms involved in epithelial cells damages.
J Nephropharmacol 2015;4:1–3.
36. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury.
Int Rev Cell Mol Biol 2012;298:229–317.
37. Kinra M, Mudgal J, Arora D, Nampoothiri M. An insight into the role of cyclooxygenase and lipooxygenase pathway in renal ischemia.
Eur Rev Med Pharmacol Sci 2017;21:5017–5020.
38. Feitoza CQ, Semedo P, Gonçalves GM, et al. Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.
Inflamm Res 2010;59:167–175.
39. Hwang HS, Yang KJ, Park KC, et al. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and pros-taglandin E2.
Nephrol Dial Transplant 2013;28:1156–1166.
40. El Morsy EM, Ahmed MA, Ahmed AA. Attenuation of renal ischemia/reperfusion injury by açaí extract preconditioning in a rat model.
Life Sci 2015;123:35–42.